• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种通过体内监测抗原表达来定义的快速且有效的DNA疫苗接种策略。

A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.

作者信息

Bins Adriaan D, Jorritsma Annelies, Wolkers Monika C, Hung Chien-Fu, Wu T-C, Schumacher Ton N M, Haanen John B A G

机构信息

Department of Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

出版信息

Nat Med. 2005 Aug;11(8):899-904. doi: 10.1038/nm1264. Epub 2005 Jun 19.

DOI:10.1038/nm1264
PMID:15965482
Abstract

Induction of immunity after DNA vaccination is generally considered a slow process. Here we show that DNA delivery to the skin results in a highly transient pulse of antigen expression. Based on this information, we developed a new rapid and potent intradermal DNA vaccination method. By short-interval intradermal DNA delivery, robust T-cell responses, of a magnitude sufficient to reject established subcutaneous tumors, are generated within 12 d. Moreover, this vaccination strategy confers protecting humoral immunity against influenza A infection within 2 weeks after the start of vaccination. The strength and speed of this newly developed strategy will be beneficial in situations in which immunity is required in the shortest possible time.

摘要

DNA疫苗接种后的免疫诱导通常被认为是一个缓慢的过程。在此我们表明,将DNA递送至皮肤会导致抗原表达出现高度短暂的脉冲。基于这一信息,我们开发了一种新的快速有效的皮内DNA疫苗接种方法。通过短间隔皮内DNA递送,在12天内即可产生强大的T细胞反应,其强度足以排斥已形成的皮下肿瘤。此外,这种疫苗接种策略在接种开始后的2周内即可赋予针对甲型流感感染的保护性体液免疫。这种新开发策略的强度和速度在需要尽可能短的时间内产生免疫的情况下将是有益的。

相似文献

1
A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.一种通过体内监测抗原表达来定义的快速且有效的DNA疫苗接种策略。
Nat Med. 2005 Aug;11(8):899-904. doi: 10.1038/nm1264. Epub 2005 Jun 19.
2
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.通过接种高度保守的核蛋白疫苗预防多种甲型流感亚型。
Vaccine. 2005 Nov 16;23(46-47):5404-10. doi: 10.1016/j.vaccine.2005.04.047. Epub 2005 Jun 13.
3
Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.用编码与组织纤溶酶原激活剂信号序列融合的甲型流感病毒核蛋白的质粒DNA进行免疫接种,可在小鼠体内引发强烈的免疫反应并提供针对H5N1攻击的保护。
J Virol Methods. 2008 Dec;154(1-2):121-7. doi: 10.1016/j.jviromet.2008.08.011. Epub 2008 Sep 27.
4
Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination.阳离子流感病毒囊作为 DNA 疫苗接种诱导 CTL 的佐剂传递系统。
Immunol Lett. 2012 Nov-Dec;148(1):77-82. doi: 10.1016/j.imlet.2012.08.006. Epub 2012 Sep 7.
5
Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.通过在小鼠中接种表达嵌合血凝素并结合核蛋白的MHC I类限制性表位的DNA疫苗,增强对H5N1流感病毒攻击的保护性免疫。
Antiviral Res. 2009 Mar;81(3):253-60. doi: 10.1016/j.antiviral.2008.12.009. Epub 2009 Jan 9.
6
The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen.一种新型递送系统(PEI600-Tat)在以人乳头瘤病毒16型E7为模型抗原开发高效DNA疫苗中的效率。
Drug Deliv. 2009 May;16(4):196-204. doi: 10.1080/10717540902757721.
7
Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.通过皮内电穿孔法延迟给予质粒DNA可有效增强DNA启动的针对癌胚抗原的T细胞和B细胞反应。
Vaccine. 2009 Jun 8;27(28):3692-6. doi: 10.1016/j.vaccine.2009.04.013. Epub 2009 May 3.
8
Lipopolysaccharide contamination in intradermal DNA vaccination: toxic impurity or adjuvant?皮内 DNA 疫苗接种中的脂多糖污染:有毒杂质还是佐剂?
Int J Pharm. 2010 May 5;390(1):32-6. doi: 10.1016/j.ijpharm.2009.06.031. Epub 2009 Jul 2.
9
Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.通过皮内电穿孔增强对前列腺癌DNA疫苗的细胞免疫反应。
Mol Ther. 2006 Feb;13(2):320-7. doi: 10.1016/j.ymthe.2005.08.005. Epub 2005 Sep 26.
10
Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity.纳米粒配方的皮肤 DNA 疫苗中阳离子电荷的屏蔽对于抗原表达和免疫原性至关重要。
J Control Release. 2010 Jan 25;141(2):234-40. doi: 10.1016/j.jconrel.2009.09.005. Epub 2009 Sep 12.

引用本文的文献

1
Beyond the Needle: Innovative Microneedle-Based Transdermal Vaccination.超越针头:基于微针的创新型经皮接种疫苗
Medicines (Basel). 2025 Feb 7;12(1):4. doi: 10.3390/medicines12010004.
2
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial.皮内裸 DNA 疫苗接种通过 DNA 纹身术增强 IV 期黑色素瘤患者的肿瘤特异性免疫:一项 I 期临床试验。
Oncol Res Treat. 2024;47(7-8):351-359. doi: 10.1159/000537896. Epub 2024 Apr 5.
3
A novel intradermal tattoo-based injection device enhances the immunogenicity of plasmid DNA vaccines.
一种新型的基于皮内纹身的注射装置可增强质粒 DNA 疫苗的免疫原性。
NPJ Vaccines. 2022 Dec 22;7(1):172. doi: 10.1038/s41541-022-00581-y.
4
Integrative Alternative Tactics for Ixodid Control.硬蜱控制的综合替代策略
Insects. 2022 Mar 18;13(3):302. doi: 10.3390/insects13030302.
5
Fast DNA Vaccination Strategy Elicits a Stronger Immune Response Dependent on CD8CD11c Cell Accumulation.快速DNA疫苗接种策略引发更强的免疫反应,该反应依赖于CD8⁺CD11c⁺细胞的积累。
Front Oncol. 2021 Dec 7;11:752444. doi: 10.3389/fonc.2021.752444. eCollection 2021.
6
Would it be possible to have better ways and routes of administration for vaccines against COVID-19?是否有可能找到针对新冠病毒疫苗的更好的给药方式和途径?
Sao Paulo Med J. 2021 Jul-Aug;139(4):416-417. doi: 10.1590/1516-3180.2021.0316.18052021.
7
Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring.以合成信使核糖核酸进行脂质转染作为T细胞免疫监测的一种简单方法
Viruses. 2021 Jun 25;13(7):1232. doi: 10.3390/v13071232.
8
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.优化的多表位新抗原 DNA 疫苗在临床前模型和临床转化中引发新抗原特异性免疫反应。
Genome Med. 2021 Apr 21;13(1):56. doi: 10.1186/s13073-021-00872-4.
9
Tick-Tattoo: DNA Vaccination Against or Tick Proteins.Tick-Tattoo:针对 或 蜱蛋白的 DNA 疫苗接种。
Front Immunol. 2021 Feb 25;12:615011. doi: 10.3389/fimmu.2021.615011. eCollection 2021.
10
Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis.研究 BB0405 作为莱姆病新型伯氏疏螺旋体疫苗候选物
Sci Rep. 2021 Feb 26;11(1):4775. doi: 10.1038/s41598-021-84130-y.